Teresa Serrano-Gonzalez

Cordoba, AN 14004, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2.

Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2.

Journal: Cell communication and signaling : CCS

Published: September 12, 2025

Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group.

Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group.

Journal: BMC cancer

Published: July 29, 2025

Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.

Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.

Journal: Molecular therapy. Oncology

Published: October 19, 2024

SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.

SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.

Journal: Science advances

Published: October 02, 2024

Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1.

Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1.

Journal: Cancer letters

Published: October 05, 2023

Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes.

Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: June 17, 2022

Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer.

Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer.

Journal: Journal of clinical medicine

Published: August 20, 2019

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer.

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer.

Journal: EBioMedicine

Published: July 24, 2019

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with tumorlet formation: A case report and review of the literature

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with tumorlet formation: A case report and review of the literature

Journal: Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia

Published: June 06, 2019

Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.

Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: April 10, 2019

Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer.

Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer.

Journal: Journal of cellular and molecular medicine

Published: May 28, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026